Overall, these results demonstrate that NKG2A is a functional IC in Vδ2 TILs and that the anti-tumor effector functions of NKG2A+ Vδ2 TILs are finely tuned by the degree of HLA-E expression on tumor target cells. This evidence concerns the gene KLRC1 and neoplasm.